193 related articles for article (PubMed ID: 27905895)
1. Mortality along the continuum of HIV care in Rwanda: a model-based analysis.
Bendavid E; Stauffer D; Remera E; Nsanzimana S; Kanters S; Mills EJ
BMC Infect Dis; 2016 Dec; 16(1):728. PubMed ID: 27905895
[TBL] [Abstract][Full Text] [Related]
2. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme.
Nsanzimana S; Kanters S; Remera E; Forrest JI; Binagwaho A; Condo J; Mills EJ
Lancet HIV; 2015 May; 2(5):e208-15. PubMed ID: 26423003
[TBL] [Abstract][Full Text] [Related]
3. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
4. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
[TBL] [Abstract][Full Text] [Related]
5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
6. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
Haas AD; Zaniewski E; Anderegg N; Ford N; Fox MP; Vinikoor M; Dabis F; Nash D; Sinayobye JD; Niyongabo T; Tanon A; Poda A; Adedimeji AA; Edmonds A; Davies MA; Egger M;
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29479867
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
[TBL] [Abstract][Full Text] [Related]
8. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
Johnson LF; May MT; Dorrington RE; Cornell M; Boulle A; Egger M; Davies MA
PLoS Med; 2017 Dec; 14(12):e1002468. PubMed ID: 29232366
[TBL] [Abstract][Full Text] [Related]
9. Determinants of mortality and loss to follow-up among adults enrolled in HIV care services in Rwanda.
Mugisha V; Teasdale CA; Wang C; Lahuerta M; Nuwagaba-Biribonwoha H; Tayebwa E; Ingabire E; Ingabire P; Sahabo R; Twyman P; Abrams EJ;
PLoS One; 2014; 9(1):e85774. PubMed ID: 24454931
[TBL] [Abstract][Full Text] [Related]
10. The proportion of loss to follow-up from antiretroviral therapy (ART) and its association with age among adolescents living with HIV in sub-Saharan Africa: A systematic review and meta-analysis.
Leshargie CT; Demant D; Burrowes S; Frawley J
PLoS One; 2022; 17(8):e0272906. PubMed ID: 35951621
[TBL] [Abstract][Full Text] [Related]
11. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
[TBL] [Abstract][Full Text] [Related]
12. Interventions to Reduce Loss to Follow-up During All Stages of the HIV Care Continuum in Sub-Saharan Africa: A Systematic Review.
Keane J; Pharr JR; Buttner MP; Ezeanolue EE
AIDS Behav; 2017 Jun; 21(6):1745-1754. PubMed ID: 27578001
[TBL] [Abstract][Full Text] [Related]
13. Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries.
McNairy ML; Lamb MR; Abrams EJ; Elul B; Sahabo R; Hawken MP; Mussa A; Zwede A; Justman J; El-Sadr WM;
J Acquir Immune Defic Syndr; 2015 Oct; 70(2):e44-51. PubMed ID: 26375466
[TBL] [Abstract][Full Text] [Related]
14. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
[TBL] [Abstract][Full Text] [Related]
15. How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
Ross J; Ingabire C; Umwiza F; Gasana J; Munyaneza A; Murenzi G; Nsanzimana S; Remera E; Akiyama MJ; Anastos KM; Adedimeji A
PLoS One; 2021; 16(5):e0251645. PubMed ID: 33984044
[TBL] [Abstract][Full Text] [Related]
16. How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa.
Slaymaker E; Todd J; Marston M; Calvert C; Michael D; Nakiyingi-Miiro J; Crampin A; Lutalo T; Herbst K; Zaba B
Glob Health Action; 2014; 7():22789. PubMed ID: 24762982
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.
Zürcher K; Mooser A; Anderegg N; Tymejczyk O; Couvillon MJ; Nash D; Egger M;
Trop Med Int Health; 2017 Apr; 22(4):375-387. PubMed ID: 28102610
[TBL] [Abstract][Full Text] [Related]
18. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.
Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A
Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
20. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
Nsanzimana S; Remera E; Kanters S; Chan K; Forrest JI; Ford N; Condo J; Binagwaho A; Mills EJ
Lancet Glob Health; 2015 Mar; 3(3):e169-77. PubMed ID: 25701995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
